DIA 48th Annual Meeting
Click here to go to the previous page
Implications of Mobile Health and Clinical Research
Track
:
Track 07: Processes and Technologies for Clinical Research
Program Code:
133
Date:
Monday, June 25, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Nancie Celini, CAB Inc., United States
PRESENTER
(S):
Craig Lipset, Head of Clinical Innovation, Pfizer Inc.
Ronald Poropatich, US Army Medical Research and Material Command (USAMRMC), United States David Scher, DLS Healthcare Consulting, LLC, United States
Description
What is mHealth? What does mHealth offer (or threaten) for clinical research? This forum presents diverse accounts of mHealth at work in the real world in order to consider the implications (both promise and threats) for the conduct of clinical research trials.
Learning Objectives:
Define potential applications of mHealth in clinical research
Describe some of the benefits of mHealth for patients
Identify key policy issues that concern the wide adoption of clinical research in health care and research.
Learning Objectives:
Define potential applications of mHealth in clinical research
Describe some of the benefits of mHealth for patients
Identify key policy issues that concern the wide adoption of clinical research in health care and research.
This session is a part of:
Handout Online
